PENUMBRA COIL 400
Report
- Report Number
- 3005168196-2014-00417
- Event Type
- Malfunction
- Date Received
- June 24, 2014
- Date of Event
- May 21, 2014
- Report Date
- May 27, 2014
- Manufacturer
- PENUMBRA, INC.
- Product Code
- HCG
- PMA / PMN Number
- K120330
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THE EVENT DESCRIPTION HAS BEEN CORRECTED TO INCLUDE "EMBOLIZATION" VS "THROMBECTOMY." CONCLUSION: AFTER FURTHER PROFESSIONAL MEDICAL REVIEW, IT WAS DETERMINED BY THE MANUFACTURER THAT THIS EVENT DOES NOT FALL INTO A "SERIOUS INJURY" CATEGORY. THE MANUFACTURER HAS UPDATED ITS RECORDS TO REFLECT THIS CHANGE. NO FURTHER INFORMATION IS AVAILABLE.
CONCLUSION: THE PRODUCT WAS NOT RETURNED FOR EVALUATION AS THE DEVICE WAS IMPLANTED IN THE PATIENT. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS. THIS MDR IS ASSOCIATED WITH MDR 3005168196-2014-00418 AND 00419. DEVICE WAS IMPLANTED IN THE PATIENT.
THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE USING THE PENUMBRA COIL 400. FOLLOWING A SUCCESSFUL PROCEDURE, AND THE USE OF THREE PENUMBRA COILS, THE PATIENT HAD A HEADACHE THAT THE PHYSICIANS ATTRIBUTED TO AN INFLAMMATORY RESPONSE TO THE COIL MASS AND CLOT WITHIN THE ANEURYSM DOME. THE PHYSICIAN GAVE THE PATIENT A DOSE OF VICODIN AND THE EVENT WAS RESOLVED.
THE PATIENT WAS UNDERGOING AN EMBOLIZATION PROCEDURE USING PENUMBRA COIL'S 400. FOLLOWING THE PROCEDURE AFTER USING THREE DIFFERENT PENUMBRA COIL'S 400, THE PATIENT HAD A HEADACHE THAT THE PHYSICIANS ATTRIBUTED TO AN INFLAMMATORY RESPONSE TO THE COIL MASS AND CLOT WITHIN THE ANEURYSM DOME. THE PHYSICIAN GAVE THE PATIENT A DOSE OF VICODIN AND THE EVENT WAS RESOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 367463 | PENUMBRA COIL 400 | HCG, KRD | HCG | PENUMBRA, INC. | F28815 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR | Other |